Catalytic asymmetric synthesis represents a cornerstone in modern organic chemistry, enabling the creation of chiral molecules with high levels of stereocontrol. This field addresses the challenge of selectively synthesizing molecules with a desired spatial arrangement of atoms, crucial for pharmaceuticals, agrochemicals, and materials science. Unlike traditional asymmetric synthesis methods that often rely on stoichiometric chiral reagents, catalytic asymmetric synthesis employs chiral catalysts to facilitate the formation of enantioenriched products from achiral or prochiral substrates. One prominent strategy in catalytic asymmetric synthesis involves the use of transition metal complexes as catalysts. These complexes exploit the inherent chirality of the ligands coordinated to the metal center to induce asymmetry in the reaction. Ligands such as chiral phosphines, N-heterocyclic carbenes, and binaphthyl-based compounds have been extensively employed for this purpose. The catalytic cycle typically involves substrate coordination, stereochemically controlled transformations, and product release, all under the influence of the chiral catalyst.
Another significant approach is organocatalysis, which employs small organic molecules as catalysts to induce chirality. Organocatalysts often feature functional groups capable of mediating asymmetric transformations through non-covalent interactions, such as hydrogen bonding, ion pairing, or π-π stacking. Prominent examples include proline derivatives, chiral amines, and thioureas, which have found widespread use in various asymmetric transformations. Overall, catalytic asymmetric synthesis offers a powerful toolkit for accessing enantioenriched compounds with high efficiency and selectivity. Ongoing research efforts continue to expand the scope of catalytic systems, exploring new catalyst designs, reaction mechanisms, and substrate scopes to address the growing demand for chiral molecules in diverse fields.
Title : Nanomaterials to fight cancer, cysts, infection, and numerous other health ailments: Human data
Thomas J Webster, Brown University, United States
Title : Application of vanadium, tantalum and chromium single-site zeolite catalysts in catalysis
Stanislaw Dzwigaj, Sorbonne University, France
Title : Influence of various catalysts on H₂ enhancement and CO2 capture during syngas upgrading
Enrico Paris, CREA-IT & DIAEE, Italy
Title : Plasma deposited nanocomposite thin films as integrated catalytic systems on structured packings: Concepts and applications
Hanna Kierzkowska Pawlak, Lodz University of Technology, Poland
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model via bi-odesign, bio- and chemical engineering, translational applications, and upgraded business modeling to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : The Concept and Implications of Low Carbon Green Growth
Dai Yeun Jeong, Asia Climate Change Education Center, Korea, Republic of
Title : Post-translational modifications of proteins in cardiovascular diseases
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Morphological studies of quaternary alloys
Yarub Al Douri, European Academy of Sciences, Belgium
Title : Advances in heterogeneous catalysis for green conversion of propene to aldehydes and alcohols
Ram Sambhar Shukla, CSIR-Central Salt and Marine Chemicals Research Institute (CSMCRI), India
Title : Advanced nanostructures for carbon neutrality and sustainable H₂ energy
Tokeer Ahmad, Jamia Millia Islamia, India